about
Decreased plasma levels of soluble CD18 link leukocyte infiltration with disease activity in spondyloarthritisProteomics characterization of extracellular space components in the human aortaZinc in Multiple Sclerosis: A Systematic Review and Meta-AnalysisActivated protein C: A regulator of human skin epidermal keratinocyte functionNeuroendocrine immunoregulation in multiple sclerosisSelective Allosteric Inhibition of MMP9 Is Efficacious in Preclinical Models of Ulcerative Colitis and Colorectal CancerBiochemistry and molecular biology of gelatinase B or matrix metalloproteinase-9 (MMP-9): the next decadeRole of platelets in neuroinflammation: a wide-angle perspectiveOxidative damage and antioxidative therapy in systemic sclerosisIncreased degradation of extracellular matrix structures of lacrimal glands implicated in the pathogenesis of Sjögren's syndrome.AP-1 mediated transcriptional repression of matrix metalloproteinase-9 by recruitment of histone deacetylase 1 in response to interferon βIncreased expression of Matrix Metalloproteinase 9 in liver from NZB/W F1 mice received antibody against human parvovirus B19 VP1 unique region proteinMatricellular proteins and matrix metalloproteinases mark the inflammatory and fibrotic response in human cardiac allograft rejection.A self-propagating matrix metalloprotease-9 (MMP-9) dependent cycle of chronic neutrophilic inflammation.Osteoclast-like Cells in Early Zebrafish EmbryosPostnatal hyperoxia exposure differentially affects hepatocytes and liver haemopoietic cells in newborn ratsPathogenic implications of iron accumulation in multiple sclerosis.A possible contribution of altered cathepsin B expression to the development of skin sclerosis and vasculopathy in systemic sclerosisMelatonin inhibits matrix metalloproteinase-9 activity by binding to its active site.Glycine tomentella Hayata inhibits IL-1β and IL-6 production, inhibits MMP-9 activity, and enhances RAW264.7 macrophage clearance of apoptotic cellsRegulation of MMP-9 by a WIN-binding site in the monocyte-macrophage system independent from cannabinoid receptors.Estrogen treatment decreases matrix metalloproteinase (MMP)-9 in autoimmune demyelinating disease through estrogen receptor alpha (ERalpha).Human parvovirus B19 NS1 protein aggravates liver injury in NZB/W F1 mice.Intense inflammation and nerve damage in early multiple sclerosis subsides at older age: a reflection by cerebrospinal fluid biomarkers.Relationship between cerebrospinal fluid biomarkers for inflammation, demyelination and neurodegeneration in acute optic neuritisMacrophage depletion ameliorates nephritis induced by pathogenic antibodies.Expression of matrix metalloproteinases 9 and 12 in actinic cheilitisBarx2 and Fgf10 regulate ocular glands branching morphogenesis by controlling extracellular matrix remodeling.Leukocyte transmigration across endothelial and extracellular matrix protein barriers in liver ischemia/reperfusion injury.Matrix metalloproteinase-9 inhibition reduces inflammation and improves motility in murine models of postoperative ileus.Matrix metalloproteinases in liver injury, repair and fibrosis.In Vivo and Impression Cytology Study on the Effect of Compatible Solutes Eye Drops on the Ocular Surface Epithelial Cell Quality in Dry Eye PatientsAberrant Wound Healing in an Epidermal Interleukin-4 Transgenic Mouse Model of Atopic DermatitisFamily Analysis of Linkage and Association of HLA-DRB1, CTLA4, TGFB1, IL4, CCR5, RANTES, MMP9 and TIMP1 Gene Polymorphisms with Multiple SclerosisQuercetin and sulforaphane in combination suppress the progression of melanoma through the down-regulation of matrix metalloproteinase-9.Contractile, but not endothelial, dysfunction in early inflammatory arthritis: a possible role for matrix metalloproteinase-9Matrix metalloproteinase (MMP)-9: a proximal biomarker for cardiac remodeling and a distal biomarker for inflammation.Induction of heme oxygenase-1 is a beneficial response in a murine model of venous thrombosisEffects of human parvovirus B19 VP1 unique region protein on macrophage responses.Inducible nitric oxide synthase deficiency impairs matrix metalloproteinase-9 activity and disrupts leukocyte migration in hepatic ischemia/reperfusion injury.
P2860
Q22000831-17F77EC3-36A5-46A7-A6C1-EF12A522291EQ24321762-487B08D5-4521-4D78-813F-8AC16B761B96Q26747289-45782D99-6C2A-4111-B46E-8C9A6C3D592CQ26830499-FB3B550F-4A30-41C4-A4A0-3BF7A0B06514Q26864449-92911B1E-FEDA-4716-A82B-61D7C5185816Q27306938-62FEF485-CD0B-4E73-919D-BD3AAE4D04A0Q28288148-AC7B0812-334A-40B0-B60D-17E00544DA86Q28393808-86DD0A90-1962-484B-8FB7-4DED823EF504Q28394733-3FFC57EF-36B1-4548-986A-99C873ADB7CCQ30833276-3DD591A4-69E4-488E-8C02-1BC8877CE24DQ31081621-92FEB717-3BB4-40AA-9BE0-3FB4277F9675Q33383620-A3F5902C-0D92-4502-B770-C488562D3D89Q33732614-711F295B-132F-4992-A98D-6A51FAB45B44Q33797926-E6A89B48-253F-4109-89DB-F0DB1134B853Q33810680-12F39428-AEDA-422D-9EB0-80E452ADD6D1Q34035591-9F269688-AEE1-4177-8376-CAC104E51E99Q34049616-A6984F5B-94A7-4911-8A94-AF1FA25C865EQ34182447-EF98B66A-9440-41E6-9B86-0CEB859C12DAQ34323300-6F9D35EE-D118-475C-B8B3-9652659565E6Q34335518-8B1F007D-834E-442E-89B6-E7D466ECF9ABQ34471928-3E32C460-BBC2-4639-864A-D94065197EA4Q34610688-2778B8F9-9335-421C-B725-7D8F318DB293Q34652025-1D4633C8-F286-4D6D-B1BB-B84CDC9C92EFQ34718044-F34058F8-01E6-49FF-8DA5-B4E03FCEB8ECQ35015106-12292990-DEAC-4B89-8CF3-B7B825631938Q35071158-27B1D760-23C9-4F4F-B353-3E1332DB918BQ35092940-9DCD35DF-7C71-4FAE-9D2A-9EA83EBA2875Q35098173-7B24E581-2A37-4E03-89E7-748CBFA8C24CQ35167030-4281A400-5180-4306-96A6-D7A6F5C3CBE8Q35269654-D5D2CEC0-FCC4-487F-8AE0-847F9AE3AF95Q35830977-0C3E8032-806C-4AD9-B3FE-9AC2B7EFA47CQ35843885-CC1C8A18-CCC9-4E62-88B8-9CEF6891C4F0Q35890345-B74F3B5F-E39A-4319-A617-A8A20FEBA71FQ35944470-7C6E800F-80AA-4EBC-AE1F-0B4E9E413EF6Q36246689-D67CE9E3-AFD0-4E39-8690-B82A933BE32DQ36253978-4DA588FB-20D3-41F5-B24E-B7CBC1207A17Q36863958-345E5503-5823-4222-98CC-E4469A9405E9Q37061125-354B301F-4E90-4250-8669-FB72F84E77FDQ37122784-993D9BD8-4529-4B01-8D19-9FB5FF053730Q37197391-F7C9DC02-C394-4F6E-98F5-E9DB0AEB4392
P2860
description
2006 nî lūn-bûn
@nan
2006 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Matrix metalloproteinase-9 and autoimmune diseases
@ast
Matrix metalloproteinase-9 and autoimmune diseases
@en
Matrix metalloproteinase-9 and autoimmune diseases
@nl
type
label
Matrix metalloproteinase-9 and autoimmune diseases
@ast
Matrix metalloproteinase-9 and autoimmune diseases
@en
Matrix metalloproteinase-9 and autoimmune diseases
@nl
prefLabel
Matrix metalloproteinase-9 and autoimmune diseases
@ast
Matrix metalloproteinase-9 and autoimmune diseases
@en
Matrix metalloproteinase-9 and autoimmune diseases
@nl
P50
P3181
P1476
Matrix metalloproteinase-9 and autoimmune diseases
@en
P2888
P304
P3181
P356
10.1007/S10875-006-9022-6
P407
P577
2006-07-01T00:00:00Z
P6179
1020224886